ReviewRSC advances2019
New dimensions in calix[4]pyrrole: the land of opportunity in supramolecular chemistry.
Review in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 76 citations in OpenAlex.
- Synthesis and uranyl(VI) extraction performance of a calix[4]pyrrole-tetrahydroxamic acid receptor.Beilstein journal of organic chemistry · 2026Article
- The V-Shaped Hamilton Receptors: A Paradigmatic Multipurpose Scaffold.ChemistryOpen · 2026Review
- Nitrogen monoxide and calix[4]pyrrolato aluminate: structural constraint enabled NO dimerization.Chemical science · 2024Article
- Evaluation of naked-eye sensing and anion binding studies inRSC advances · 2024Article
- Site-selective chlorination of pyrrolic heterocycles by flavin dependent enzyme PrnC.Communications chemistry · 2024Article
- Advances in the use of metal-free tetrapyrrolic macrocycles as catalysts.Beilstein journal of organic chemistry · 2024Review
- Facile synthesis and anion binding studies of fluorescein/benzo-12-crown-4 ether based bis-dipyrromethane (DPM) receptors.RSC advances · 2023Article
- Azacrown-calixpyrrole isosteres: receptors and sensors for anions.Chemical science · 2023Article
- Dithieno[3,2-RSC advances · 2022Review
- Article
- Synthesis of Novel One-WalledACS omega · 2022Article
- An Efficient and Versatile Deep Eutectic Solvent-Mediated Green Method for the Synthesis of Functionalized Coumarins.ACS omega · 2022Article
- Supramolecular Fluorescent Sensors: An Historical Overview and Update.Coordination chemistry reviews · 2021Article
- Design, synthesis and photophysical properties of novel star-shaped truxene-based heterocycles utilizing ring-closing metathesis, Clauson-Kaas, Van Leusen and Ullmann-type reactions as key tools.Beilstein journal of organic chemistry · 2021Article
- Molecular recognition of pyrazineChemical science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The quest for receptors endowed with the selective complexation and detection of negatively charged species continues to receive substantial consideration within the scientific community worldwide. This study is encouraged by the utilization of anions in nature in a plethora of biological systems such as chloride channels and proteins and as polyanions for genetic information. The molecular recognition of anionic species is greatly interesting in terms of their favourable interactions. In this comprehensive review, in addition to giving accounts of some selected syntheses, we illustrated diverse applications ranging from molecular containers to ion transporters and drug carriers of a supramolecular receptor named calix[4]pyrrole. We believe that the present review may act as a catalyst in enhancing the novel applications of calix[4]pyrrole and its congeners in the other dimensions of science and technology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.